- About Liver Cancer
- Risks and Prevention
- Potential Treatment Options
- Additional Information
- About Covidien IO
- For Caregivers
- Find a Physician
Questions to Ask Your Doctor
TACE involves blocking (embolizing) blood vessels to cut off the blood supply to a tumor while directly injecting it with high doses of cancer-killing drugs (chemotherapy). Depriving the tumor of blood allows for a higher dose of chemotherapy drugs and keeps the anti-cancer drugs in contact with the tumor longer. Because the blood supply is temporarily blocked from entering other parts of the liver, the chemotherapy does not leave the targeted area. Isolating the organ inhibits the drugs from circulating throughout the body; this helps protect healthy cells from exposure to the drugs.
TACE may slow disease progression in liver cancer patients. For primary liver cancer, doctors may combine TACE with other therapies in a liver cancer treatment plan.
TACE is often used to treat small HCC (primary liver cancer) tumors that have a thick capsule (border, envelope, casing) because such tumors receive blood almost exclusively from the hepatic artery. TACE often shrinks tumors suited to this treatment, sometimes in preparation for surgical resection, a liver transplant, PEI or ablation. TACE is not ideal for treating non-vascular tumors, those with minimal blood supply.
TAE blocks (embolizes) blood vessels to cut off the blood supply to a tumor but without the use of chemotherapy.
Who performs TACE and TAE?
TACE and TAE are performed primarily by interventional radiologists and sometimes by surgeons and other medical specialists. TACE and TAE are most often performed in consultation with a medical oncologist (cancer specialist).
Questions to ask your doctor about TACE
Questions to ask your doctor about TAE